Whittier Trust Co. Has $12.55 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Whittier Trust Co. boosted its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 4.4% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 41,804 shares of the medical instruments supplier's stock after purchasing an additional 1,779 shares during the quarter. Whittier Trust Co. owned about 0.06% of West Pharmaceutical Services worth $12,547,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Fidelis Capital Partners LLC bought a new stake in shares of West Pharmaceutical Services during the first quarter worth $27,000. Crewe Advisors LLC boosted its holdings in West Pharmaceutical Services by 322.7% in the second quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier's stock valued at $31,000 after acquiring an additional 71 shares during the last quarter. Northwest Investment Counselors LLC bought a new position in West Pharmaceutical Services in the first quarter valued at about $40,000. Hazlett Burt & Watson Inc. bought a new position in West Pharmaceutical Services in the first quarter valued at about $40,000. Finally, ORG Partners LLC boosted its holdings in West Pharmaceutical Services by 820.0% in the first quarter. ORG Partners LLC now owns 138 shares of the medical instruments supplier's stock valued at $55,000 after acquiring an additional 123 shares during the last quarter. Institutional investors own 93.90% of the company's stock.

West Pharmaceutical Services Trading Down 2.1 %

West Pharmaceutical Services stock traded down $6.07 during mid-day trading on Monday, hitting $287.25. The stock had a trading volume of 301,445 shares, compared to its average volume of 550,653. The stock has a 50-day simple moving average of $299.96 and a two-hundred day simple moving average of $324.52. The stock has a market capitalization of $20.84 billion, a PE ratio of 40.86, a P/E/G ratio of 10.46 and a beta of 1.01. West Pharmaceutical Services, Inc. has a 12 month low of $265.00 and a 12 month high of $413.70. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03.

West Pharmaceutical Services (NYSE:WST - Get Free Report) last issued its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.74 by ($0.22). The company had revenue of $702.10 million for the quarter, compared to the consensus estimate of $729.36 million. West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. West Pharmaceutical Services's quarterly revenue was down 6.9% on a year-over-year basis. During the same quarter last year, the business posted $2.11 EPS. As a group, sell-side analysts forecast that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current year.

Insider Buying and Selling at West Pharmaceutical Services

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of the firm's stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total value of $308,700.00. Following the completion of the transaction, the vice president now directly owns 1,478 shares in the company, valued at $443,400. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.53% of the company's stock.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.